BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10225759)

  • 1. Present status of apheresis technologies: Part 2. Membrane plasma fractionator.
    Sueoka A
    Ther Apher; 1997 May; 1(2):135-46. PubMed ID: 10225759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present status of apheresis technologies: Part 1. Membrane plasma separator.
    Sueoka A
    Ther Apher; 1997 Feb; 1(1):42-8. PubMed ID: 10225780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present status of apheresis technologies: part 4. Leukocyte filter.
    Sueoka A
    Ther Apher; 1998 Feb; 2(1):78-86. PubMed ID: 10227794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of apheresis technologies, part 3: adsorbent.
    Sueoka A
    Ther Apher; 1997 Aug; 1(3):271-83. PubMed ID: 10225751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.
    Sueoka A
    Ther Apher; 2000 Jun; 4(3):211-2. PubMed ID: 10910022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranes for therapeutic apheresis.
    Nakaji S; Yamamoto T
    Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane pore size and filtration selectivity in cryoglobulinemic plasma fractionation.
    Zborowski M; Malchesky PS; Duggan PA; Koo AP
    ASAIO Trans; 1991; 37(3):M490-1. PubMed ID: 1751247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of membrane technologies for therapeutic apheresis.
    Sueoka A
    Ther Apher; 1998 Nov; 2(4):252-6. PubMed ID: 10227750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of operating conditions on selectivity of a plasma fractionator in double filtration plasmapheresis.
    Mineshima M; Yokoi R; Horibe K; Eguchi K; Kaneko I; Agishi T; Akiba T
    Ther Apher; 2001 Dec; 5(6):444-8. PubMed ID: 11800078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane plasmapheresis in the United States: a review over the last 20 years.
    Siami GA; Siami FS
    Ther Apher; 2001 Aug; 5(4):315-20. PubMed ID: 11724518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma separator Plasmaflo OP.
    Hirata N; Shizume Y; Shirokaze J; Suemitsu J; Yoshida H; Yamawaki N
    Ther Apher Dial; 2003 Feb; 7(1):64-8. PubMed ID: 12921117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
    Wang T; Xu B; Fan R; Liu Z; Gong D
    J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of membrane plasma separation and plasma filtration techniques.
    Samtleben W; Schmidt B; Blumenstein M; Gurland HJ
    Int J Artif Organs; 1985 Jul; 8 Suppl 2():33-4. PubMed ID: 4055111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two filter combinations for low-density lipoprotein apheresis by membrane differential filtration: a prospective crossover controlled clinical study.
    Matic G; Kohlschein P; Wallstab U; Tiess M; Winkler R; Prophet H; Ramlow W; Schuff-Werner P
    Artif Organs; 2002 Apr; 26(4):371-7. PubMed ID: 11952509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL-apheresis: results of longterm treatment and vascular outcome.
    Keller C
    Atherosclerosis; 1991 Jan; 86(1):1-8. PubMed ID: 2064631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of membrane trapping in plasma fractionator on separative characteristics.
    Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
    Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomodulation effects of extracorporeal circulation in apheresis.
    Malchesky PS; Nosè Y
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):42-51. PubMed ID: 2658097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement metabolism during membrane plasma separation.
    McLeod BC; Viernes A; Sassetti RJ
    Artif Organs; 1983 Nov; 7(4):443-9. PubMed ID: 6651583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apheresis without substitution fluid: devices, directions and limitations.
    Gurland HJ; Lysaght MJ; Samtleben W; Schmidt B; Stoffner D
    Life Support Syst; 1984; 2(1):39-45. PubMed ID: 6471909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-based therapeutic plasma exchange (mTPE): Technical and clinical experience.
    Gashti CN; Andreoli DC; Patel D
    J Clin Apher; 2018 Feb; 33(1):38-45. PubMed ID: 28608569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.